MedTrace Logo

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

NCT05940272 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2025-10-09

No results posted yet for this study

Summary

The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients about their lymphoma diagnosis and advance care planning.

Conditions

  • Lymphoma, B-Cell
  • Lymphoma
  • Large-cell Lymphoma
  • Large B-cell Lymphoma
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Mediastinal B-Cell Diffuse Large Cell Lymphoma

Interventions

BEHAVIORAL

Hematolo-GIST Training

Hematologist will participate in a group Hematolo-GIST training provided remotely via the study team.

BEHAVIORAL

Participants Appointment

Participants will meet with Hematolo-GIST trained hematologists. Participants will consent to having their appointment audio-recorded on password-protected devices or MSK approved secure platforms.

Sponsors & Collaborators

Principal Investigators

  • Kelly McConnell, PhD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-03
Primary Completion
2028-07-03
Completion
2028-07-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05940272 on ClinicalTrials.gov